CPSF6-RARG-positive acute myeloid leukaemia resembles acute promyelocytic leukaemia but is insensitive to retinoic acid and arsenic trioxide

Pathology. 2023 Apr;55(3):407-412. doi: 10.1016/j.pathol.2022.07.011. Epub 2022 Sep 20.

Authors

Ji Li¹, Wen-Zhe Yan¹, Li-Hong Bai¹, Ya-Feng Jiang¹, Hong-Ling Peng¹, Jian-Kai Shen¹, Rui-Juan Li²

Affiliations

¹ Department of Hematology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
² Department of Hematology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China. Electronic address: ruijuanli@csu.edu.cn.

PMID: 36241556
DOI: 10.1016/j.pathol.2022.07.011

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents* / therapeutic use
Antineoplastic Combined Chemotherapy Protocols
Arsenic Trioxide / therapeutic use
Humans
Leukemia, Myeloid, Acute* / drug therapy
Leukemia, Promyelocytic, Acute* / drug therapy
Retinoic Acid Receptor gamma
Tretinoin / therapeutic use

Substances

Antineoplastic Agents
Arsenic Trioxide
Tretinoin
cleavage factor Im, human